A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)

被引：0
|
作者：
Masashi Kanai
Etsuro Hatano
Shogo Kobayashi
Yutaka Fujiwara
Shigeru Marubashi
Atsushi Miyamoto
Hisanori Shiomi
Shoji Kubo
Shinichi Ikuta
Hiroaki Yanagimoto
Hiroaki Terajima
Hisashi Ikoma
Daisuke Sakai
Yuzo Kodama
Satoru Seo
Satoshi Morita
Tetsuo Ajiki
Hiroaki Nagano
Tatsuya Ioka
机构：
[1] Kyoto University,Department of Clinical Oncology and Pharmacogenomics, Graduate School of Medicine
[2] Kyoto University,Department of Surgery, Graduate School of Medicine
[3] Osaka University,Department of Surgery, Graduate School of Medicine
[4] National Cancer Center Hospital,Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center
[5] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Surgery
[6] National Hospital Organization Osaka National Hospital,Department of Surgery
[7] Shiga University of Medical Science,Department of Surgery
[8] Osaka City University Graduate School of Medicine,Department of Hepato
[9] Meiwa General Hospital,Biliary
[10] Kansai Medical University,Pancreatic Surgery
[11] Kitano Hospital,Department of Surgery
[12] Kyoto Prefectural University of Medicine,Department of Surgery
[13] Osaka University,Department of Gastroenterological Surgery and Oncology
[14] Kyoto University Hospital,Division of Digestive Surgery, Department of Surgery
[15] Kyoto University Graduate School of Medicine,Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine
[16] Kobe University Hospital,Department of Gastroenterology and Hepatology, Graduate School of Medicine
[17] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Biomedical Statistics and Bioinformatics
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Biliary; Gemcitabine; Cisplatin; S-1; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 300
页数：7
相关论文
共 50 条
  • [21] A multicenter phase II study of gemcitabine plus S-1 chemotherapy for advanced biliary tract cancer
    Arima, S.
    Shimizu, K.
    Okamoto, T.
    Toki, S.
    Kasuga, A.
    Kitamura, H.
    Takasu, A.
    Nagashima, F.
    Sugiyama, M.
    Furuse, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S627 - S627
  • [22] A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer
    Arima, Shiho
    Shimizu, Kyoko
    Okamoto, Tomoyoshi
    Toki, Masao
    Suzuki, Yutaka
    Okano, Naohiro
    Naruge, Daisuke
    Kawai, Kirio
    Kobayashi, Takaaki
    Kasuga, Akiyoshi
    Kitamura, Hiroshi
    Takasu, Atuko
    Nagashima, Fumio
    Sugiyama, Masanori
    Furuse, Junji
    ANTICANCER RESEARCH, 2017, 37 (02) : 909 - 914
  • [23] Randomised phase III study of gemcitabine, cisplatin plus S-1 (GCS) compared with gemcitabine plus cisplatin (GC) for unresectable or recurrent biliary tract cancer (KHBO1401-MITSUBA).
    Ioka, Tatsuya
    Kanai, Masashi
    Kobayashi, Shogo
    Sakai, Daisuke
    Kitasato, Amane
    Yamaue, Hiroki
    Hayashi, Hideyuki
    Chayahara, Naoko
    Takahashi, Masahiro
    Yamada, Takatsugu
    Hatano, Etsuro
    Goto, Takuma
    Fujimoto, Jiro
    Murakami, Masahiro
    Kamei, Keiko
    Yoshimura, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Ichiro Yasuda
    Nobuo Toda
    Hirofumi Kogure
    Keiji Hanada
    Hiroyuki Maguchi
    Naoki Sasahira
    Hideki Kamada
    Tsuyoshi Mukai
    Yoshihiro Okabe
    Osamu Hasebe
    Iruru Maetani
    Kazuhiko Koike
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 973 - 979
  • [25] A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Yasuda, Ichiro
    Toda, Nobuo
    Kogure, Hirofumi
    Hanada, Keiji
    Maguchi, Hiroyuki
    Sasahira, Naoki
    Kamada, Hideki
    Mukai, Tsuyoshi
    Okabe, Yoshihiro
    Hasebe, Osamu
    Maetani, Iruru
    Koike, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 973 - 979
  • [26] Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma
    Kang, Myoung Joo
    Lee, Jae-Lyun
    Kim, Tae Won
    Lee, Sung Sook
    Ahn, Shin
    Park, Do Hyun
    Lee, Sang Soo
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    ACTA ONCOLOGICA, 2012, 51 (07) : 860 - 866
  • [27] Phase II study of S-1 in patients with advanced biliary tract cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Takezako, Y
    Morizane, C
    BRITISH JOURNAL OF CANCER, 2004, 91 (10) : 1769 - 1774
  • [28] Phase II study of S-1 in patients with advanced biliary tract cancer
    H Ueno
    T Okusaka
    M Ikeda
    Y Takezako
    C Morizane
    British Journal of Cancer, 2004, 91 : 1769 - 1774
  • [29] Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Park, Byung Kyu
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Kim, Kyung Sik
    Choi, Jin-Sub
    Lee, Woo Jung
    Song, Si Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) : 999 - 1003
  • [30] A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Kim, ST
    Park, JO
    Lee, J
    Lee, KT
    Lee, JK
    Choi, SH
    Heo, JS
    Park, YS
    Kang, WK
    Park, K
    CANCER, 2006, 106 (06) : 1339 - 1346
12345